Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C

被引：0
|
作者：
Shivakumar Narayanan
Kerry Townsend
Thomas Macharia
Adrian Majid
Amy Nelson
Robert R. Redfield
Shyam Kottilil
Rohit Talwani
Anu Osinusi
机构：
[1] University of Maryland School of Medicine,Division of Infectious Diseases, Institute of Human Virology
[2] National Institutes of Health,Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases
来源：
Hepatology International | 2014年 / 8卷
关键词：
Sofosbuvir; Ribavirin; HCV monoinfection; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：560 / 566
页数：6
相关论文
共 50 条
  • [31] Future prospects for hepatitis C treatment: Without interferon and ribavirin?
    Lens, Sabela
    Alfaro, Ignacio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2014, 37 (05): : 311 - 321
  • [32] Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C
    Magdalena Figlerowicz
    Wojciech Sluzewski
    Arleta Kowala-Piaskowska
    Iwona Mozer-Lisewska
    European Journal of Pediatrics, 2004, 163 : 265 - 267
  • [33] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [34] Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C
    Figlerowicz, M
    Sluzewski, W
    Kowala-Piaskowska, A
    Mozer-Lisewska, I
    EUROPEAN JOURNAL OF PEDIATRICS, 2004, 163 (4-5) : 265 - 267
  • [35] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [36] Ribavirin in the treatment of hepatitis C
    Abonyi, ME
    Lakatos, PL
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1315 - 1320
  • [37] Localized scleroderma occurring after treatment of chronic hepatitis C with sofosbuvir and ribavirin
    Waki, Yuma
    Kamiya, Koji
    Maekawa, Takeo
    Komine, Mayumi
    Murata, Satoru
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2019, 46 (01): : E34 - E35
  • [38] RIBAVIRIN IN TREATMENT OF HEPATITIS C
    Abonyi, Margit E.
    Lakatos, Peter L.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3415 - 3415
  • [39] Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C
    Sjogren, MH
    Sjogren, R
    Holtzmuller, K
    Winston, B
    Butterfield, B
    Drake, S
    Watts, A
    Howard, R
    Smith, M
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 727 - 732
  • [40] Lymphocyte subsets in interferon treatment or interferon plus ribavirin treatment of chronic hepatitis C
    Macedo, G
    Correia, A
    Fernandes, N
    Sarmento, J
    Vale, A
    Ramos, JP
    Candeias, J
    Ribeiro, T
    HEPATOLOGY, 1998, 28 (04) : 704A - 704A
12345